Cargando…
Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122
SIMPLE SUMMARY: Targeting epigenetic alterations in hepatocellular carcinoma (HCC) provides therapeutic options in addition to traditional treatments. The aim of our study was to evaluate the potential of targeting histone methyltransferase G9a in the development of a therapeutic target. We confirme...
Autores principales: | Yuan, Lan-Ting, Lee, Wei-Jiunn, Yang, Yi-Chieh, Chen, Bo-Rong, Yang, Ching-Yao, Chen, Min-Wei, Chen, Ji-Qing, Hsiao, Michael, Chien, Ming-Hsien, Hua, Kuo-Tai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157135/ https://www.ncbi.nlm.nih.gov/pubmed/34069116 http://dx.doi.org/10.3390/cancers13102376 |
Ejemplares similares
-
Prognostic value of hsa-mir-299 and hsa-mir-7706 in hepatocellular carcinoma
por: Wang, Fenglin, et al.
Publicado: (2018) -
miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma
por: Shyu, Yu-Chiau, et al.
Publicado: (2016) -
3′UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma
por: Hua, Kuo-Tai, et al.
Publicado: (2017) -
Comprehensive Bioinformatics Analysis of Key Methyltransferases and Demethylases for Histone Lysines in Hepatocellular Carcinoma
por: Zheng, Yang, et al.
Publicado: (2020) -
Histone Demethylase Retinoblastoma Binding Protein 2 is Overexpressed in Hepatocellular Carcinoma and Negatively Regulated by hsa-miR-212
por: Liang, Xiuming, et al.
Publicado: (2013)